Results 281 to 290 of about 95,731 (301)

Pharmacological inhibitors of cyclin-dependent kinases

Trends in Pharmacological Sciences, 2002
Paul Greengard, Laurent Meijer, Marie Knockaert   +2 more
exaly  

Inhibition of Cyclin-Dependent Kinases Improves CA1 Neuronal Survival and Behavioral Performance after Global Ischemia in the Rat

Journal of Cerebral Blood Flow and Metabolism, 2002
Ruth Slack, David Park, Dale Corbett
exaly  

Cyclin dependent kinases in cancer

Cancer Biology and Therapy, 2012
Noopur Raje
exaly  

Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle

Current Opinion in Cell Biology, 2000
Steven I Reed, S I Reed
exaly  

ATP-site Directed Inhibitors of Cyclin-dependent Kinases

Current Medicinal Chemistry, 1999
Christian Doerig, Laurent Meijer
exaly  

The history and future of targeting cyclin-dependent kinases in cancer therapy

Nature Reviews Drug Discovery, 2015
Erik Knudsen, Witkiewicz Agnieszka K, Turner Nicholas C   +2 more
exaly  

Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016)

Expert Opinion on Investigational Drugs, 2016
Adriana Chilin, Ettore Novellino, Antonio Lavecchia   +2 more
exaly  

Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein

Expert Opinion on Investigational Drugs, 2006
Józefa Wesierska-Gadek
exaly  

Cyclin‐Dependent Kinase

2006
openaire   +2 more sources

Cyclin-Dependent Kinases

2013
A. Camins, J.G. Pizarro, J. Folch
openaire   +1 more source